Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2010-05, Vol.21 (suppl-5), p.v155-v157 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | v157 |
|---|---|
| container_issue | suppl-5 |
| container_start_page | v155 |
| container_title | Annals of oncology |
| container_volume | 21 |
| creator | Harousseau, J.-L. Dreyling, M. |
| description | |
| doi_str_mv | 10.1093/annonc/mdq178 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733456758</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733456758</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-edffe8940cb65e0161cf0d4f92c80a70946f010b491fd76445e936d2dc3063243</originalsourceid><addsrcrecordid>eNpFkM1LHDEYh0Op1FV77LXk1oujbyYfM_Emi1_gYqEKspeQTd6UaGZmTWao_veurNrTC-_v4Tk8hPxgcMRA82Pb90Pvjjv_xJr2C5kxqXTVgmBfyQx0zatGcrFL9kp5AACla_2N7NYgpQTVzshyMaUxrhPS7gXT0NkTevZncUPnKfbR2UR_Z-vG6JBeTNHj5ouFhiFTH-3ffiixHNIxox077Edqe78ZUxr-VdP6gOwEmwp-f7_75O787HZ-WV3fXFzNT68rx5UeK_QhYKsFuJWSCEwxF8CLoGvXgm1ACxWAwUpoFnyjhJCoufK1dxwUrwXfJ7-23nUeniYso-licZiS7XGYimk4F1I1st2Q1ZZ0eSglYzDrHDubXwwD81bTbGuabc0N__PdPK069J_0R77_wlhGfP7cbX40quGNNJf3SyNbqRd6vjTAXwEQA4FO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733456758</pqid></control><display><type>article</type><title>Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Harousseau, J.-L. ; Dreyling, M.</creator><creatorcontrib>Harousseau, J.-L. ; Dreyling, M. ; ESMO Guidelines Working Group</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdq178</identifier><identifier>PMID: 20555068</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Calcium - blood ; Creatinine - blood ; Drug Therapy, Combination ; Europe - epidemiology ; Follow-Up Studies ; Humans ; Immunoglobulin A - analysis ; Immunoglobulin G - analysis ; Immunoglobulin M - analysis ; Incidence ; Multiple Myeloma - diagnosis ; Multiple Myeloma - pathology ; Multiple Myeloma - therapy ; Myeloma Proteins - analysis ; Myeloma Proteins - urine ; Neoplasm Staging ; Randomized Controlled Trials as Topic ; Risk Assessment ; Secondary Prevention ; Treatment Outcome</subject><ispartof>Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v155-v157</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-edffe8940cb65e0161cf0d4f92c80a70946f010b491fd76445e936d2dc3063243</citedby><cites>FETCH-LOGICAL-c369t-edffe8940cb65e0161cf0d4f92c80a70946f010b491fd76445e936d2dc3063243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20555068$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harousseau, J.-L.</creatorcontrib><creatorcontrib>Dreyling, M.</creatorcontrib><creatorcontrib>ESMO Guidelines Working Group</creatorcontrib><title>Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><subject>Calcium - blood</subject><subject>Creatinine - blood</subject><subject>Drug Therapy, Combination</subject><subject>Europe - epidemiology</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Immunoglobulin A - analysis</subject><subject>Immunoglobulin G - analysis</subject><subject>Immunoglobulin M - analysis</subject><subject>Incidence</subject><subject>Multiple Myeloma - diagnosis</subject><subject>Multiple Myeloma - pathology</subject><subject>Multiple Myeloma - therapy</subject><subject>Myeloma Proteins - analysis</subject><subject>Myeloma Proteins - urine</subject><subject>Neoplasm Staging</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Risk Assessment</subject><subject>Secondary Prevention</subject><subject>Treatment Outcome</subject><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM1LHDEYh0Op1FV77LXk1oujbyYfM_Emi1_gYqEKspeQTd6UaGZmTWao_veurNrTC-_v4Tk8hPxgcMRA82Pb90Pvjjv_xJr2C5kxqXTVgmBfyQx0zatGcrFL9kp5AACla_2N7NYgpQTVzshyMaUxrhPS7gXT0NkTevZncUPnKfbR2UR_Z-vG6JBeTNHj5ouFhiFTH-3ffiixHNIxox077Edqe78ZUxr-VdP6gOwEmwp-f7_75O787HZ-WV3fXFzNT68rx5UeK_QhYKsFuJWSCEwxF8CLoGvXgm1ACxWAwUpoFnyjhJCoufK1dxwUrwXfJ7-23nUeniYso-licZiS7XGYimk4F1I1st2Q1ZZ0eSglYzDrHDubXwwD81bTbGuabc0N__PdPK069J_0R77_wlhGfP7cbX40quGNNJf3SyNbqRd6vjTAXwEQA4FO</recordid><startdate>201005</startdate><enddate>201005</enddate><creator>Harousseau, J.-L.</creator><creator>Dreyling, M.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201005</creationdate><title>Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up</title><author>Harousseau, J.-L. ; Dreyling, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-edffe8940cb65e0161cf0d4f92c80a70946f010b491fd76445e936d2dc3063243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Calcium - blood</topic><topic>Creatinine - blood</topic><topic>Drug Therapy, Combination</topic><topic>Europe - epidemiology</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Immunoglobulin A - analysis</topic><topic>Immunoglobulin G - analysis</topic><topic>Immunoglobulin M - analysis</topic><topic>Incidence</topic><topic>Multiple Myeloma - diagnosis</topic><topic>Multiple Myeloma - pathology</topic><topic>Multiple Myeloma - therapy</topic><topic>Myeloma Proteins - analysis</topic><topic>Myeloma Proteins - urine</topic><topic>Neoplasm Staging</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Risk Assessment</topic><topic>Secondary Prevention</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harousseau, J.-L.</creatorcontrib><creatorcontrib>Dreyling, M.</creatorcontrib><creatorcontrib>ESMO Guidelines Working Group</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harousseau, J.-L.</au><au>Dreyling, M.</au><aucorp>ESMO Guidelines Working Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2010-05</date><risdate>2010</risdate><volume>21</volume><issue>suppl-5</issue><spage>v155</spage><epage>v157</epage><pages>v155-v157</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>20555068</pmid><doi>10.1093/annonc/mdq178</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v155-v157 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_733456758 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Calcium - blood Creatinine - blood Drug Therapy, Combination Europe - epidemiology Follow-Up Studies Humans Immunoglobulin A - analysis Immunoglobulin G - analysis Immunoglobulin M - analysis Incidence Multiple Myeloma - diagnosis Multiple Myeloma - pathology Multiple Myeloma - therapy Myeloma Proteins - analysis Myeloma Proteins - urine Neoplasm Staging Randomized Controlled Trials as Topic Risk Assessment Secondary Prevention Treatment Outcome |
| title | Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T22%3A50%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20myeloma:%20ESMO%20Clinical%20Practice%20Guidelines%20for%20diagnosis,%20treatment%20and%20follow-up&rft.jtitle=Annals%20of%20oncology&rft.au=Harousseau,%20J.-L.&rft.aucorp=ESMO%20Guidelines%20Working%20Group&rft.date=2010-05&rft.volume=21&rft.issue=suppl-5&rft.spage=v155&rft.epage=v157&rft.pages=v155-v157&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdq178&rft_dat=%3Cproquest_cross%3E733456758%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733456758&rft_id=info:pmid/20555068&rfr_iscdi=true |